Related references
Note: Only part of the references are listed.Advances in Lentivirus Purification
Ana Sofia Moreira et al.
BIOTECHNOLOGY JOURNAL (2021)
Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies
Alexander F. Haddad et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives
Cristina Birzu et al.
CANCERS (2021)
Non-Thermal Biocompatible Plasma Jet Induction of Apoptosis in Brain Cancer Cells
Mahmuda Akter et al.
CELLS (2021)
Clinically Explored Virus-Based Therapies for the Treatment of Recurrent High-Grade Glioma in Adults
Amanda V. Immidisetti et al.
BIOMEDICINES (2021)
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma
Jorge A. Benitez et al.
NEURO-ONCOLOGY (2021)
Viral vector: potential therapeutic for glioblastoma multiforme
Ceera Manikandan et al.
CANCER GENE THERAPY (2020)
Human adenovirus binding to host cell receptors: a structural view
Aleksandra Cecylia Stasiak et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2020)
Using Light for Therapy of Glioblastoma Multiforme (GBM)
Alex Vasilev et al.
BRAIN SCIENCES (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
E. Antonio Chiocca et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Oncolytic Virotherapy in Glioma Tumors
Sergio Rius-Rocabert et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
HSV-1 Cytoplasmic Envelopment and Egress
Imran Ahmad et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis
Zhi-Ze Xiao et al.
FRONTIERS IN NEUROLOGY (2020)
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma A Randomized Clinical Trial
Timothy F. Cloughesy et al.
JAMA ONCOLOGY (2020)
Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma
Seidu A. Richard
DISEASE MARKERS (2020)
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Mercedes M. Riley et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential
Casey Anthony et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Molecular targeted therapy of glioblastoma
Emilie Le Rhun et al.
CANCER TREATMENT REVIEWS (2019)
DNX-2401: an investigational drug for the treatment of recurrent glioblastoma
Brandon Philbrick et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells
Raghupathy Vengoji et al.
CARCINOGENESIS (2019)
Glioblastoma Treatment Modalities besides Surgery
Hao Zhang et al.
JOURNAL OF CANCER (2019)
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
Maryam Moradi Binabaj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Sequencing the next generation of glioblastomas
Ivana Jovcevska
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth
Laura Sanchez-Hernandez et al.
GENE THERAPY (2018)
Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma
Dipongkor Saha et al.
IMMUNOTHERAPY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience
Yukinori Akiyama et al.
WORLD NEUROSURGERY (2018)
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
Martina Da Ros et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Treatment of glioblastoma in adults
Wolfgang Wick et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice
Alexandre Roux et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
Kei Hiraoka et al.
NEURO-ONCOLOGY (2017)
Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
Leah A. Mitchell et al.
NEURO-ONCOLOGY (2017)
Oncolytic Virotherapy for the Treatment of Malignant Glioma
Paul M. Foreman et al.
NEUROTHERAPEUTICS (2017)
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
Assia L. Angelova et al.
VIRUSES-BASEL (2017)
Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
Kevin A. Cassady et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review
Ron Batash et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Recent advances and future of immunotherapy for glioblastoma
Neha Kamran et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Antonin Drean et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Challenges of up-scaling lentivirus production and processing
Alexandra McCarron et al.
JOURNAL OF BIOTECHNOLOGY (2016)
Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma
Dwijit GuhaSarkar et al.
NEURO-ONCOLOGY (2016)
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F. Cloughesy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Antonin Drean et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)
Giulio Cabrini et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Glioblastoma multiforme: Pathogenesis and treatment
Constantinos Alifieris et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Characterization of the non-specific DNA binding properties of the Adenoviral IVa2 protein
Teng-Chieh Yang et al.
BIOPHYSICAL CHEMISTRY (2014)
Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector
M. Takahashi et al.
CANCER GENE THERAPY (2014)
Adenoviral vector-mediated gene therapy for gliomas: coming of age
Maria G. Castro et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
Glioblastoma cancer stem cells: Biomarker and therapeutic advances
Kelli B. Pointer et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Emerging Therapies for Glioblastoma
Alissa A. Thomas et al.
JAMA NEUROLOGY (2014)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Omar D. Perez et al.
MOLECULAR THERAPY (2012)
Gene therapy for brain tumors: Basic developments and clinical implementation
Hikmat Assi et al.
NEUROSCIENCE LETTERS (2012)
Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression
Charn-Jung Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Adenoviral virotherapy for malignant brain tumors
Suvobroto Nandi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Design and application of oncolytic HSV vectors for glioblastoma therapy
Paola Grandi et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Replication-competent retrovirus vectors for cancer gene therapy
Chien-Kuo Tai et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Chemoresistance in gliomas
Chen Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas
Peter Forsyth et al.
MOLECULAR THERAPY (2008)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL
Norman Kock et al.
NEOPLASIA (2007)
The use of oncolytic vaccinia viruses in the treatment of cancer: A new role for an old ally?
SH Thorne et al.
CURRENT GENE THERAPY (2005)
Adenoviral vectors for gene transfer and therapy
C Volpers et al.
JOURNAL OF GENE MEDICINE (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
Multimutated herpes simplex virus G207 is a potent inhibitor of angiogenesis
J Cinatl et al.
NEOPLASIA (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes
J Yoshida et al.
HUMAN GENE THERAPY (2004)
Rev response elements (RRE) in lentiviruses: An RNAMotif algorithm-based strategy for RRE prediction
MA Lesnik et al.
MEDICINAL RESEARCH REVIEWS (2002)
Replication-selective viruses for cancer therapy
C Biederer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015
F McCormick
SEMINARS IN CANCER BIOLOGY (2000)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling et al.
GENE THERAPY (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Share Paper
